Advanced Cholesterol Management in Dubai

A basic lipid profile test in Dubai is typically affordable and covered by most insurance plans when ordered by a physician. Comprehensive panels including advanced markers like lipoprotein(a) and apolipoprotein B may have additional costs. Contact our clinic for current pricing and to verify your insurance coverage for lipid testing.

Desirable total cholesterol is below 200 mg/dL (5.2 mmol/L). LDL should be below 100 mg/dL for most adults and below 70 mg/dL for high-risk patients. HDL should be above 40 mg/dL for men and above 50 mg/dL for women. Triglycerides should be below 150 mg/dL. However, optimal targets depend on your individual cardiovascular risk profile, which your doctor will assess during your consultation.

For some patients with mildly elevated cholesterol and low cardiovascular risk, lifestyle modifications alone may be sufficient. This includes reducing saturated and trans fat intake, increasing soluble fiber, regular exercise of at least 150 minutes per week, weight loss, and smoking cessation. However, patients with high cardiovascular risk, very high LDL, or familial hypercholesterolemia typically require medication alongside lifestyle changes to reach target levels.

The most commonly reported statin side effect is muscle pain or weakness, affecting about 5 to 10 percent of patients. Other potential effects include mild liver enzyme elevation, digestive issues, and rarely, increased blood sugar levels. Most patients tolerate statins well, and the cardiovascular benefits far outweigh the risks for those who need them. If you experience side effects, your doctor can adjust the dose, switch to a different statin, or use alternative medications.

Adults should have a baseline lipid profile by age 20 and repeat testing every 4 to 6 years if levels are normal and risk is low. After age 40, or if you have risk factors such as diabetes, hypertension, family history of heart disease, or obesity, more frequent testing every 1 to 2 years is recommended. Patients on lipid-lowering medication should be tested 6 to 12 weeks after starting or changing therapy, then annually once stable.

Familial hypercholesterolemia (FH) is a genetic condition causing very high LDL cholesterol from birth, significantly increasing the risk of early heart disease. It affects about 1 in 250 people. Signs include very high LDL above 190 mg/dL, family history of early heart attacks, and sometimes visible cholesterol deposits around the eyes or tendons. Early diagnosis and aggressive treatment with high-intensity statins and additional medications are essential to prevent cardiovascular events.

Yes, diet plays an important role in cholesterol management. Reducing saturated fats (found in red meat, full-fat dairy, and fried foods), eliminating trans fats, increasing soluble fiber (oats, beans, fruits), eating fatty fish rich in omega-3s, and adding plant sterols can collectively reduce LDL cholesterol by 10 to 15 percent. However, for many patients, dietary changes alone are insufficient to reach guideline-recommended targets, and medication is needed alongside a healthy diet.

LDL (low-density lipoprotein) is often called bad cholesterol because it deposits cholesterol in artery walls, leading to atherosclerosis and increasing heart attack and stroke risk. HDL (high-density lipoprotein) is called good cholesterol because it helps remove excess cholesterol from arteries and transport it back to the liver for disposal. Treatment focuses primarily on lowering LDL to target levels based on your cardiovascular risk.